Equipment supplement to "Training Innate Immunity: A new approach to the treatment of sepsis"
Equipment supplement to "Training Innate Immunity: A new approach to the treatment of sepsis"
批准号:
10794766
负责人:
EDWARD R SHERWOOD
金额:
$13.63万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-04-01 至 2025-05-31
关键词:
20 year oldAntibiotic ResistanceAwardCandida albicansCause of DeathChromatographyEquipmentExpenditureFDA approvedGlucansHospitalsImmuneImmunityImmunosuppressive AgentsIncidenceInnate Immune SystemIntensive Care UnitsLaboratoriesNatural ImmunityParentsPatientsPerformancePharmaceutical PreparationsPhenotypePrevention approachProceduresProcessQuality ControlReagentResearchSepsisSourceSystemTrainingaging populationbeta-Glucanscognitive disabilitydetectoreffective therapyexperimental studyhospital readmissionnovelnovel strategiesopportunistic pathogenphysically handicappedpreventrecurrent infectionresponsesecondary infectiontrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Sepsis is the leading cause of death in non-cardiac intensive care units (ICU) and accounts for 40% of ICU
expenditures. Patients that survive sepsis have long term physical and cognitive disabilities and are frequently
readmitted to the hospital with recurrent infections. Over the past two decades there has been an increased
incidence of sepsis and this trend is likely to continue due to our aging population, increased use of
immunosuppressive drugs and invasive procedures and the emergence of antibiotic resistant opportunistic
pathogens. Attempts at developing effective therapies to prevent or treat sepsis have proven to be exceedingly
difficult. No drugs are currently approved by the FDA for the treatment of sepsis. It is clear that new
approaches for the prevention and treatment of sepsis are needed. In the parent award (RO1GM119197), we
proposed the novel concept that it is possible to “train” the innate immune system to facilitate a more effective
response to existing and secondary infections. In this research, we utilize β-glucan isolated from C. albicans to
induce trained immunity. The β-glucan reagent is prepared in the PIs (Williams) laboratory and it is the immune
training reagent used for the experiments detailed in the parent award at both ETSU (Williams) and Vanderbilt
(Sherwood). In fact, the Williams laboratory is the “sole source” of the β-glucan immune training reagent which
is employed in the parent award. The isolation and quality control of β-glucan is a multi-step process, which
requires chromatographic purification at the preparative level in order to obtain a high purity, i.e. >95%, β-
glucan reagent in quantities sufficient for the experiments being done at both ETSU and Vanderbilt. Our
current preparative chromatography system is twenty years old. It is currently not operational and must be
replaced. This supplement requests an Agilent 1260 Infinity II preparative chromatography system. The Agilent
1260 system is a high performance, fully automated preparative chromatography system with multiple
detectors that will enable us to isolate and purify sufficient quantities of -glucan in order to complete the
specific aims of our parent award.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1042/cs20150592
发表时间:
2016-03
期刊:
Clinical science (London, England : 1979)
影响因子:
--
作者:
[Stark RJ, Choi H, Koch SR, Fensterheim BA, Lamb FS, Sherwood ER]
通讯作者:
Sherwood ER
DOI:
10.1097/shk.0000000000000688
发表时间:
2017-01
期刊:
Shock (Augusta, Ga.)
影响因子:
--
作者:
[Patil NK, Bohannon JK, Luan L, Guo Y, Fensterheim B, Hernandez A, Wang J, Sherwood ER]
通讯作者:
Sherwood ER
Development of Negative Controls for Fc-C-Type Lectin Receptor Probes.
Fc-C 型凝集素受体探针阴性对照的开发。
DOI:
10.1128/spectrum.01135-23
发表时间:
2023-06-15
期刊:
MICROBIOLOGY SPECTRUM
影响因子:
3.7
作者:
[Hatinguais, Remi, Kay, Madalaine, Salazar, Fabian, Conn, Daniel P. P., Williams, David L. L., Cook, Peter C. C., Willment, Janet A. A., Brown, Gordon D. D.]
通讯作者:
Brown, Gordon D. D.
IL-15 Enables Septic Shock by Maintaining NK Cell Integrity and Function.
IL-15通过维持NK细胞完整性和功能来启用败血性休克。
DOI:
10.4049/jimmunol.1601486
发表时间:
2017-02-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Guo Y, Luan L, Patil NK, Wang J, Bohannon JK, Rabacal W, Fensterheim BA, Hernandez A, Sherwood ER]
通讯作者:
Sherwood ER
DOI:
10.4049/jimmunol.1602106
发表时间:
2017-04-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Fensterheim BA, Guo Y, Sherwood ER, Bohannon JK]
通讯作者:
Bohannon JK
共 7 条
Macrophage mitochodrial reprogramming and innate immune memory
-
批准号:10550138
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2020
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Macrophage mitochodrial reprogramming and innate immune memory
-
批准号:10333362
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2020
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Training Innate Immunity: A new approach to the treatment of Sepsis
-
批准号:10296894
-
项目类别:
-
资助金额:$55.35万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Training Innate Immunity: A new approach to the treatment of Sepsis
-
批准号:10461115
-
项目类别:
-
资助金额:$52.84万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Equipment Supplement request for a BD LSR Fortessa Flow Cytometer
-
批准号:9275190
-
项目类别:
-
资助金额:$12.74万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Training Innate Immunity: A new approach to the treatment of Sepsis
-
批准号:10669060
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7256520
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7811704
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8578744
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8292209
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8509831
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:9091565
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8112517
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7086177
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8692836
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:6766014
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:6911533
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:6681426
-
项目类别:
-
资助金额:$26.17万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8908015
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7786482
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
海外基金